Heng‐Ying Pu
Impact in
- Cancer Research top 2%
- Cancer-related molecular mechanisms research
- Cancer, Hypoxia, and Metabolism
- Cancer Genomics and Diagnostics
- Cancer, Lipids, and Metabolism
- Health Informatics top 5%
Papers in
-
- Cancer-related molecular mechanisms research 7
- Cancer Genomics and Diagnostics 3
- Cancer, Hypoxia, and Metabolism 3
- Cancer, Lipids, and Metabolism 2
- MicroRNA in disease regulation 2
-
- RNA modifications and cancer 6
- RNA Research and Splicing 3
- Co-authors
- Rui‐Hua Xu (11 shared papers)Ze-Xian Liu (10 shared papers)Huai‐Qiang Ju (7 shared papers)Zhao-Lei Zeng (7 shared papers)De‐Shen Wang (4 shared papers)Qi‐Nian Wu (8 shared papers)Qi-Nian Wu (2 shared papers)Qi Zhao (4 shared papers)
- Journals
- Signal Transduction and Targeted Therapy (2 papers)Oncogene (2 papers)Clinical and Translational Medicine (2 papers)Nature Communications (2 papers)Cancer Research (2 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Heng‐Ying Pu
19 papers receiving 2.3k citations
Heng‐Ying Pu's Hit Papers
Peers
Comparison fields: 5 of 107
- Cancer Research 1.1k
- Health Informatics 37
- Molecular Biology 1.2k
- Oncology 369
- Pulmonary and Respiratory Medicine 391
Countries citing papers authored by Heng‐Ying Pu
This map shows the geographic impact of Heng‐Ying Pu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heng‐Ying Pu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heng‐Ying Pu more than expected).
Fields of papers citing papers by Heng‐Ying Pu
This network shows the impact of papers produced by Heng‐Ying Pu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heng‐Ying Pu. The network helps show where Heng‐Ying Pu may publish in the future.
Co-authors
The 25 scholars most cited alongside Heng‐Ying Pu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 388 | |
| 2 | Circulating tumor DNA methylation profiles enable early diagnosis, prognosis prediction, and screening for colorectal cancer Hit paper breakdown → | 2020 | 345 |
| 3 | 2019 | 321 | |
| 4 | 2018 | 295 | |
| 5 | Phosphorylated NFS1 weakens oxaliplatin-based chemosensitivity of colorectal cancer by preventing PANoptosis Hit paper breakdown → | 2022 | 256 |
| 6 | 2020 | 161 | |
| 7 | 2018 | 149 | |
| 8 | 2011 | 72 | |
| 9 | 2021 | 59 | |
| 10 | 2020 | 53 | |
| 11 | 2022 | 51 | |
| 12 | 2015 | 45 | |
| 13 | 2022 | 43 | |
| 14 | 2023 | 33 | |
| 15 | 2017 | 25 | |
| 16 | 2024 | 21 | |
| 17 | 2022 | 9 | |
| 18 | 2018 | 8 | |
| 19 | 2023 | 5 |
About Heng‐Ying Pu
Heng‐Ying Pu is a scholar working on Cancer Research, Molecular Biology, Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Epidemiology, having authored 19 papers that have together received 2.3k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (7 papers), RNA modifications and cancer (6 papers), Cancer Genomics and Diagnostics (3 papers), RNA Research and Splicing (3 papers), Cancer, Hypoxia, and Metabolism (3 papers), Cancer, Lipids, and Metabolism (2 papers), Ferroptosis and cancer prognosis (2 papers) and MicroRNA in disease regulation (2 papers). The work is most often cited by research in Cancer Research (1.1k citations), Health Informatics (37 citations), Molecular Biology (1.2k citations), Oncology (369 citations) and Pulmonary and Respiratory Medicine (391 citations). Heng‐Ying Pu has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Rui‐Hua Xu, Ze-Xian Liu, Huai‐Qiang Ju, Zhao-Lei Zeng, De‐Shen Wang, Qi‐Nian Wu, Qi-Nian Wu, Qi Zhao, Ying Jin and Xiao-Jing Luo. Their work appears in journals such as Signal Transduction and Targeted Therapy, Oncogene, Clinical and Translational Medicine, Nature Communications and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.